Deutsche Bank AG (NYSE:DB) was nailed with a $14 billion fine from the DOJ last week because of shady actions during the financial crisis. While a fine was expected, the massive size of the fine was not. There is palpable fear that Deutsche Bank will not be able to pay the fine and may be insolvent. Even though it is expected that the fine will be reduced by more than 50%, it is still more than was expected. The stock is hammering on a triple bottom on the chart. While this is support, investors need to be extremely aware of a possible breakdown. A triple bottom break would likely mean a run on the bank and a crisis in the banking sector in Europe. This is huge. Every investor should be on high alert here. One of the best trades may be to short European financial players or buy puts. It may get very ugly.

Read more: Bank Crisis Looms, Deutsche Bank Breaking This Level Will Trigger Bankruptcy

Natural gas broke out on the daily chart today. This is a strong breakout with significant upside between 10-20%. The United States Natural Gas Fund, LP (NYSEARCA:UNG) can be seen in the stock chart below hammering on the trend line multiple times until it broke out today. Chatter is strong amongst institutions that a squeeze could hit in the next few days. Price action dictates natural gas is a strong buy here.

Read more: Buy $UNG: Natural Gas Just Broke Out In A Major Way

Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial

NEW YORK - September 20, 2016 (Investorideas.com Newswire) Actinium Pharmaceuticals, Inc. (NYSE: ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that the Company has selected Vector Oncology as its Clinical Research Organization (CRO) for its anticipated Actimab-A Phase 2 clinical trial.

"We are delighted to be working with Vector Oncology for our upcoming Phase 2 clinical trial," stated Dragan Cicic, M.D., Actinium’s Chief Medical Officer. "Vector Oncology displayed an expertise in hematology clinical trials with an emphasis on Phase 2 studies, which gives us great confidence in our selection. We look forward to working with Vector Oncology and to benefiting from their robust clinical capabilities."

Read more: Actinium Pharmaceuticals ( ATNM )

Guardian Patch Location Technology Successfully Tracks Object Within 50 Square Mile Radius in First Live Testing Demonstration

SAN DIEGO, CA - September 20, 2016 (Investorideas.com Newswire) Gopher Protocol Inc. (OTCQB:GOPH) ("Gopher" and the "Company"), a development-stage Company which specializes in the development of real-time, heuristic-based mobile technologies, and its partner, Guardian Patch LLC, announce that they have successfully completed the first live demonstration and testing of the Guardian Patch (the "Patch") location technology that works with or without GPS. The demonstration of the "GOPHERINSIGHT™" circuit prototype device, which took place in San Diego, California on September 14, 2016 between 10:00 AM - 11:00 AM PT, proved range coverage of approximately 50 square miles. The Patch is a "stick-on" device that provides its users with the capability to protect and track objects, such as valuable personal belongings, children and loved-ones, and even family pets, through a mobile application. The demonstration of the Patch was completed in the San Diego area within a densely populated urban area. More than 1,000 active followers watched the live demonstration using the Guardian Mobile App.

Read more: Gopher Protocol's ( GOPH )

Exploration Update; Completion of first three Diamond Drill holes at the El Colomo Gold-Silver Project in Mexico

Vancouver, British Columbia - September 20, 2016 (Investorideas.com Newswire) Gainey Capital Corp. (TSXV: GNCOTCQX: GNYPF) recently reported that the Phase 1 Drilling campaign has completed the first three Diamond Drill holes at the El Colomo Gold-Silver Project in Mexico. The first of the three holes targeting the La Nueva Victoria Mineralized Zone has been sampled and shipped to ALS Labs Vancouver, BC for analysis and the other two holes are currently being processed at the Company’s core logging facility to be submitted shortly. Preliminary results from these drill holes are anticipated within the next few weeks.

Furthermore, the Company is pleased to announce that the program continues to advance with the commencement of drilling on the first of four targets at the La Higuerita/El Arrayan Mineralized Zones.

Read more: Gainey ( GNC / GNYPF )